BOEING CO/THE (BA) Fundamental Analysis & Valuation

NYSE:BA • US0970231058

231.11 USD
+9.05 (+4.08%)
At close: Mar 6, 2026
230.383 USD
-0.73 (-0.31%)
After Hours: 3/6/2026, 8:04:00 PM

This BA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, BA scores 2 out of 10 in our fundamental rating. BA was compared to 78 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BA have multiple concerns. BA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. BA Profitability Analysis

1.1 Basic Checks

  • In the past year BA has reported negative net income.
  • In the past year BA had a positive cash flow from operations.
  • In the past 5 years BA reported 4 times negative net income.
  • In multiple years BA reported negative operating cash flow during the last 5 years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • The Return On Assets of BA (1.12%) is comparable to the rest of the industry.
  • BA has a Return On Equity of 34.65%. This is amongst the best in the industry. BA outperforms 93.59% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • BA has a Profit Margin of 2.11%. This is comparable to the rest of the industry: BA outperforms 50.00% of its industry peers.
  • BA's Gross Margin of 4.79% is on the low side compared to the rest of the industry. BA is outperformed by 80.77% of its industry peers.
  • BA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1

2. BA Health Analysis

2.1 Basic Checks

  • BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BA has been increased compared to 1 year ago.
  • BA has more shares outstanding than it did 5 years ago.
  • BA has a better debt/assets ratio than last year.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.36, we must say that BA is in the distress zone and has some risk of bankruptcy.
  • BA's Altman-Z score of 1.36 is on the low side compared to the rest of the industry. BA is outperformed by 76.92% of its industry peers.
  • BA has a Debt/Equity ratio of 8.37. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 8.37, BA is doing worse than 82.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC9.41%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that BA should not have too much problems paying its short term obligations.
  • BA has a worse Current ratio (1.19) than 80.77% of its industry peers.
  • A Quick Ratio of 0.40 indicates that BA may have some problems paying its short term obligations.
  • The Quick ratio of BA (0.40) is worse than 91.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

6

3. BA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 49.34% over the past year.
  • BA shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.50%.
  • BA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.81% yearly.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • BA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.39% yearly.
  • Based on estimates for the next years, BA will show a quite strong growth in Revenue. The Revenue will grow by 9.67% on average per year.
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.39%
Revenue Next Year9.98%
Revenue Next 2Y12.33%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

1

4. BA Valuation Analysis

4.1 Price/Earnings Ratio

  • BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 1143.21, which means the current valuation is very expensive for BA.
  • 61.54% of the companies in the same industry are cheaper than BA, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, BA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 1143.21
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BA does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as BA's earnings are expected to grow with 42.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.38%
EPS Next 3Y42.54%

0

5. BA Dividend Analysis

5.1 Amount

  • No dividends for BA!.
Industry RankSector Rank
Dividend Yield 0%

BA Fundamentals: All Metrics, Ratios and Statistics

BOEING CO/THE

NYSE:BA (3/6/2026, 8:04:00 PM)

After market: 230.383 -0.73 (-0.31%)

231.11

+9.05 (+4.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners71.79%
Inst Owner Change2.38%
Ins Owners0.03%
Ins Owner Change5.01%
Market Cap181.50B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.78
Price Target277.93 (20.26%)
Short Float %1.74%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.43
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)5.96%
PT rev (3m)7.72%
EPS NQ rev (1m)-226.35%
EPS NQ rev (3m)-1038.97%
EPS NY rev (1m)-89.37%
EPS NY rev (3m)-92.12%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-1.11%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1143.21
P/S 2.03
P/FCF N/A
P/OCF 170.43
P/B 33.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)0.2
Fwd EY0.09%
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)1.36
OCFY0.59%
SpS113.91
BVpS6.94
TBVpS-17.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.36
F-Score6
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.39%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year9.98%
Revenue Next 2Y12.33%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year229.27%
EBIT Next 3Y75.68%
EBIT Next 5Y46.89%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BA FAQ

What is the ChartMill fundamental rating of BOEING CO/THE (BA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BA.


What is the valuation status for BA stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.


Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 2 / 10.


Is the dividend of BOEING CO/THE sustainable?

The dividend rating of BOEING CO/THE (BA) is 0 / 10 and the dividend payout ratio is 17.51%.